Scott A. Foster
Jazz Pharmaceuticals (France)(FR)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Melanoma and MAPK Pathways, Herpesvirus Infections and Treatments, Poxvirus research and outbreaks
Most-Cited Works
- → Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells(1998)1,199 cited
- → Telomerase activation by the E6 gene product of human papillomavirus type 16(1996)823 cited
- → Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis(1996)662 cited
- → In VitroAntiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor(2010)372 cited
- → Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7.(1994)243 cited
- → Inactivation of p16 in Human Mammary Epithelial Cells by CpG Island Methylation(1998)229 cited
- → Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2(2016)214 cited
- → A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation(2018)210 cited
- → The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest(1994)185 cited
- → Carbamoyl Pyridone HIV-1 Integrase Inhibitors 3. A Diastereomeric Approach to Chiral Nonracemic Tricyclic Ring Systems and the Discovery of Dolutegravir (S/GSK1349572) and (S/GSK1265744)(2013)181 cited